Anti-Glaucoma Eye Drops Franchise in Ahmedabad

Bimatoprost + Timolol Eye Drops Supplier in Mumbai

Ophthalmic Glaucoma Care Distributor in Delhi

Eye Pressure Control Pharma Franchise in Bangalore

Bimatoprost Timolol Eye Drops Stockist in Hyderabad
Anti-Glaucoma Combination Ophthalmic Drop Manufacturer & Exporter in Chandigarh

Home/Products /bimatoprost-0-3mg-ml-timolol-5mg-ml-eye-drop

Optiprost T Eye Drop

Composition : Bimatoprost (0.3mg/ml) + Timolol (5mg/ml) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹0/-

Please Contact For Best Price

Optiprost T Eye Drop contains Bimatoprost 0.3mg/ml + Timolol 5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise combination ensures enhanced pressure control with long-term safety.

The eye drop works by increasing aqueous humor outflow through Bimatoprost and reducing aqueous humor production via Timolol, delivering comprehensive intraocular pressure management and protecting optic nerve health.

From a franchise perspective, Optiprost T Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, specialty ophthalmology clinics, and glaucoma care centers, ensuring consistent prescriptions and repeat sales.

Adding Optiprost T Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Read More

About the Product

Optiprost T Eye Drop contains Bimatoprost 0.3mg/ml + Timolol 5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise combination ensures enhanced pressure control with long-term safety.

The eye drop works by increasing aqueous humor outflow through Bimatoprost and reducing aqueous humor production via Timolol, delivering comprehensive intraocular pressure management and protecting optic nerve health.

From a franchise perspective, Optiprost T Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, specialty ophthalmology clinics, and glaucoma care centers, ensuring consistent prescriptions and repeat sales.

Adding Optiprost T Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Common side effects may include eye redness, burning or stinging sensation, itching, blurred vision, or foreign body sensation. Rarely, systemic effects such as slow heart rate, fatigue, dizziness, or breathing difficulty may occur due to Timolol. Changes in eyelash growth or iris pigmentation may occur with prolonged use.

Optiprost T Eye Drop is indicated for the management of open-angle glaucoma and ocular hypertension in patients who do not achieve adequate pressure control with single-agent therapy. It helps reduce elevated intraocular pressure and protects against optic nerve damage under ophthalmologist supervision.

Use Optiprost T Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with asthma, chronic obstructive pulmonary disease, or cardiac conditions. Inform your doctor immediately if breathing difficulty, vision changes, or severe eye irritation occurs.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.

Get in Touch